RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:The Comapny Performed, Management disappointed. argentia77 wrote:
Well to be fair the analyst only asked him what proportion i.e. percentage of the 60 product launches in the next 36 months would be based on existing drugs versus new products not currently in their portfolio. He didn't ask for any specific names or other details. I don't think that's an unreasonable question and a direct answer wouldn't have given away any trade secrets.
The ones who have worked in the field and are running the company, they know better. Secrets stop being secrets if you let them be nibbled at.
.